While the use of chimeric antigen receptor (CAR) T-cell therapy has increased ... mediated toxicities are cytokine release ...

The extracorporeal filtration system is also a potential treatment for cancer patients experiencing a cytokine storm induced by chimeric antigen receptor (CAR) T cell therapy, and other disorders ...

I started to be interested in cytokine storm in the context of patients with ... is interested in using CAR T cell therapies to treat cancer. And I'm particularly interested in using a similar ...

The drug in question, called firicabtagene autoleucel or firi-cel, is an autologous CD22 CAR-T cell therapy that had been ...

California biotech Calibr and partner AbbVie have reported the first clinical data on a new CAR-T technology, which uses "switchable" cells that ... can sometimes cause cytokine release syndrome ...

In CAR-T cell therapy, clinicians obtain T cell source material directly from a patient (autologous), or from a donor (allogeneic), modify them, and re-introduce them to the patient. Working with ...

Creating cancer therapies based around natural killer cells could offer similar levels of efficacy to CAR-T therapies ... have not shown any incidence of cytokine release syndrome – where ...

These chemicals stimulate cell pathways and allow for ... can instigate a cytokine storm. This heightened immune response doesn't happen in all people with severe infections.

Diseases such as covid-19 and influenza can be fatal due to an overreaction of the body’s immune system called a cytokine storm. Cytokines are small proteins released by many different cells in ...